Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 17/20 | 0.86 |
| ▸ | PIK3CG | P48736 | 16/20 | 0.86 |
| ▸ | PIK3R1 | P27986 | 7/20 | 0.86 |
| ▸ | PIK3CA | P42336 | 5/20 | 0.72 |
| ▸ | PIK3CB | P42338 | 4/20 | 0.72 |
| ▸ | ABL1 | P00519 | 1/20 | 0.47 |
| ▸ | SRC | P12931 | 1/20 | 0.47 |
| ▸ | MTOR | P42345 | 1/20 | 0.47 |
| ▸ | PRKDC | P78527 | 1/20 | 0.47 |
| ▸ | PIK3C2B | O00750 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11538 | 1.00 | PIK3CD (0.86) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL31655785 | 0.98 | PIK3CD (0.89) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL8616 | 0.98 | PIK3CD (0.89) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL31655828 | 0.96 | PIK3CG (0.83) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL11146 | 0.96 | PIK3CG (0.83) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL31655817 | 0.93 | PIK3CG (0.81) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL11669 | 0.93 | PIK3CG (0.81) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL9623 | 0.93 | PIK3CD (1.00) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL31655776 | 0.93 | PIK3CD (1.00) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB | |
| SCHEMBL11307 | 0.92 | PIK3CD (0.80) | PIK3CDPIK3CGPIK3R1PIK3CAPIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12350302-B2 | Dosing regime and formulations for type B adenoviruses | Akamis Bio Limited (GB) | 2025-07-08 | — | — | US | disclosed |